Resona Asset Management Co. Ltd. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 46,623 shares of the semiconductor company's stock, valued at approximately $22,666,000.
Other institutional investors also recently bought and sold shares of the company. Kieckhefer Group LLC purchased a new position in Synopsys during the fourth quarter valued at approximately $27,000. Whipplewood Advisors LLC purchased a new position in shares of Synopsys in the 4th quarter valued at $33,000. Sierra Ocean LLC bought a new position in shares of Synopsys in the 4th quarter worth $39,000. Hazlett Burt & Watson Inc. lifted its stake in shares of Synopsys by 28.6% during the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares during the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC boosted its position in Synopsys by 50.8% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company's stock valued at $48,000 after purchasing an additional 33 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Stock Up 1.5 %
Shares of Synopsys stock traded up $5.96 on Friday, reaching $412.85. 654,141 shares of the stock were exchanged, compared to its average volume of 1,085,525. The business has a 50 day moving average price of $459.56 and a two-hundred day moving average price of $498.75. The firm has a market capitalization of $63.84 billion, a price-to-earnings ratio of 28.51, a PEG ratio of 3.23 and a beta of 1.23. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $624.80.
Wall Street Analysts Forecast Growth
SNPS has been the subject of a number of recent research reports. Redburn Atlantic initiated coverage on shares of Synopsys in a report on Monday, January 13th. They issued a "buy" rating and a $600.00 target price for the company. Piper Sandler decreased their target price on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Needham & Company LLC reaffirmed a "buy" rating and issued a $650.00 price target on shares of Synopsys in a report on Thursday, February 27th. Wells Fargo & Company decreased their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. Finally, Morgan Stanley dropped their target price on Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research note on Monday, February 24th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Synopsys currently has an average rating of "Moderate Buy" and an average price target of $638.58.
View Our Latest Report on SNPS
Insider Buying and Selling at Synopsys
In other Synopsys news, insider Geus Aart De sold 15,705 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This trade represents a 11.86 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 47,909 shares of company stock worth $22,794,835. Company insiders own 0.62% of the company's stock.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.